Mathias Vormehr

Mathias Vormehr

Company: BioNTech

Job title: Director - Cancer Vaccines


How RNA-Encoded Cytokines Mediate Potent Anti-Tumor Activity When Combined With Immune Checkpoint Blockade Or Cancer Vaccines 9:00 am

Uncover how delivery of cytokines by RNA lipid nanoparticles can overcome the disadvantages of classical therapies like short half-life or low tolerability Learn how the therapeutic potential of IL-2 can be improved by optimizing it’s binding profile or by combination with IL-7 See how RNA-encoded cytokines significantly boost the efficacy of immune checkpoint blockade or…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.